Literature DB >> 418737

Familial multiple sclerosis: clinical, histocompatibility, and viral serological studies.

R Eldridge, H McFarland, J Sever, D Sadowsky, H Krebs.   

Abstract

Evaluation of presumed "multiple sclerosis families" and comparison with recently reported families has led us to the following observations: (1) Seven of our original fourteen presumptive multiple sclerosis families had to be eliminated after personal clinical evaluation of family members failed to confirm the diagnosis in a second close relative. (2) No segregation of HLA type was noted between affected and unaffected individuals in our seven bona fide multiple sclerosis families, and no consistent segregation was noted in the twenty-eight families reported elsewhere. This supports other genetic evidence that there is not a single, major gene mapping in the HLA complex which predisposes to multiple sclerosis. (3) The DW2 antigen was increased in frequency among affected members of our families, and the A3 B7 haplotype was more frequent among affected members of other families reported. But unaffected members also tended to have an increased frequency of these same antigens. (4) No relationship was noted between HLA type and antimeasles antibody titer within our families.

Entities:  

Mesh:

Substances:

Year:  1978        PMID: 418737     DOI: 10.1002/ana.410030111

Source DB:  PubMed          Journal:  Ann Neurol        ISSN: 0364-5134            Impact factor:   10.422


  14 in total

1.  Genetic segregation of multiple sclerosis and histocompatibility (HLA) haplotypes.

Authors:  M Alter; J Quevedo
Journal:  J Neurol       Date:  1979       Impact factor: 4.849

Review 2.  Multiple sclerosis: it epidemiological, genetic, and health care impact.

Authors:  R Williams; A S Rigby; M Airey; M Robinson; H Ford
Journal:  J Epidemiol Community Health       Date:  1995-12       Impact factor: 3.710

3.  Measles antibodies and kappa-lambda light chain distribution in immunoglobulins of patients affected with multiple sclerosis.

Authors:  F Bollengier; A Mahler
Journal:  J Neurol       Date:  1979-03-22       Impact factor: 4.849

4.  HLA-linked and unlinked determinants of multiple sclerosis.

Authors:  H Z Ho; J L Tiwari; R W Haile; P I Terasaki; N E Morton
Journal:  Immunogenetics       Date:  1982       Impact factor: 2.846

5.  Family studies in multiple sclerosis: HLA haplotypes of affected sib-pairs.

Authors:  H J Mayer-Rienecker; S Wegener; B Hitzschke
Journal:  Eur Arch Psychiatry Neurol Sci       Date:  1984

6.  Some epistatic two-locus models of disease. I. Relative risks and identity-by-descent distributions in affected sib pairs.

Authors:  S E Hodge
Journal:  Am J Hum Genet       Date:  1981-05       Impact factor: 11.025

7.  HLA and disease: predictions for HLA haplotype sharing in families.

Authors:  L R Weitkamp
Journal:  Am J Hum Genet       Date:  1981-09       Impact factor: 11.025

8.  Identification of a locus on mouse chromosome 3 involved in differential susceptibility to Theiler's murine encephalomyelitis virus-induced demyelinating disease.

Authors:  R W Melvold; D M Jokinen; S D Miller; M C Dal Canto; H L Lipton
Journal:  J Virol       Date:  1990-02       Impact factor: 5.103

9.  HLA and the inheritance of multiple sclerosis: linkage analysis of 72 pedigrees.

Authors:  J L Tiwari; S E Hodge; P I Terasaki; M A Spence
Journal:  Am J Hum Genet       Date:  1980-01       Impact factor: 11.025

10.  A comparison of composition and fluidity of multiple sclerosis and normal myelin.

Authors:  J M Boggs; M A Moscarello
Journal:  Neurochem Res       Date:  1980-03       Impact factor: 3.996

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.